Inventor · disambiguated record
Xavier Billot
Also filed as: BILLOT XAVIER
11 granted patents·7 pending applications·53 citations·filing 2003–2022
87Inventor score
Files withBILLOT XAVIER5BIOPROJET SOC CIV4MERCK & CO INC2MERCK FROSST CANADA2BERREBI-BERTRAND ISABELLE1
Top patents by PatentIndex Score
18 records- 0189US9255101B26,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligandsBIOPROJECT·Filed 2013·Granted Feb 9, 2016·25 cites·13 claims
- 0283US7238710B2EP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA LTD·Filed 2005·Granted Jul 3, 2007·5 cites·11 claims
- 0379US9029357B2Benzazole derivatives as histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2014·Granted May 12, 2015·4 cites·9 claims
- 0476US7053085B2EP4 receptor agonist, compositions and methods thereofMERCK & CO INC·Filed 2004·Granted May 30, 2006·7 cites·10 claims
- 0573US8802664B2Benzazole derivatives as histamine H4 receptor ligandsBERREBI-BERTRAND ISABELLE·Filed 2011·Granted Aug 12, 2014·4 cites·11 claims
- 0673USRE42562EEP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA·Filed 2007·Granted Jul 19, 2011·1 cites·20 claims
- 0771US12134608B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2022·Granted Nov 5, 2024·0 cites·18 claims
- 0871US7109223B2Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucomaMERCK & CO INC·Filed 2003·Granted Sep 19, 2006·5 cites·7 claims
- 0964US2009258918A1EP4 receptor agonist, compositions and methods thereofBILLOT XAVIER·Filed 2009·Application pending·0 cites
- 1056US11306069B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2018·Granted Apr 19, 2022·0 cites·13 claims
- 1155US2013317013A1Ep4 receptor agonist, compositions and methods thereofBILLOT XAVIER·Filed 2013·Application pending·0 cites
- 1254US2011237511A1EP4 Receptor Agonist, Compositions and Methods ThereofMERCK FROSST CANADA·Filed 2011·Application pending·0 cites
- 1352US2005239872A11,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucomaBILLOT XAVIER·Filed 2003·Application pending·0 cites
- 1451US2006270721A1EP4 receptor agonist, compositions and methods thereofHAN YONGXIN·Filed 2006·Application pending·0 cites
- 1548US7230139B2Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agentsGEMIN X BIOTECHNOLOGIES·Filed 2004·Granted Jun 12, 2007·2 cites·25 claims
- 1644US2006167081A1Ep4 receptor agonistsBILLOT XAVIER·Filed 2003·Application pending·0 cites
- 1743US2006258726A11,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseasesBILLOT XAVIER·Filed 2003·Application pending·0 cites
- 1842US9242959B2(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applicationsBIOPROJET SOC CIV·Filed 2013·Granted Jan 26, 2016·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Xavier Billot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →